Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 24.90
-0.90 (-3.49%)
Aug 3, 2026, 5:24 PM IDT
TLV:CBI Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -13.32 | -62.46 | -31.05 | -61.74 | -89.58 |
Depreciation & Amortization | 0.22 | 0.28 | 0.53 | 17.64 | 22.51 |
Loss (Gain) From Sale of Assets | - | - | - | 1.57 | - |
Loss (Gain) From Sale of Investments | 3.75 | 36 | -3 | 8.03 | 31.15 |
Loss (Gain) on Equity Investments | 12.34 | 28.57 | 17 | 22.39 | 30.81 |
Stock-Based Compensation | 0.16 | 0.14 | 0.04 | 5.15 | 5.55 |
Other Operating Activities | -7.64 | -8.91 | 5.56 | -31.76 | -43.92 |
Change in Accounts Receivable | 0.02 | 0.55 | 1.02 | -6.61 | 2.02 |
Change in Inventory | - | - | - | -2.25 | 0.58 |
Change in Accounts Payable | - | - | - | -4.2 | 5.5 |
Change in Other Net Operating Assets | 0.53 | -0.65 | 1.4 | -7.26 | -5.93 |
Operating Cash Flow | -3.95 | -6.48 | -8.51 | -59.04 | -41.33 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0.01 | -1.27 | -1.59 |
Divestitures | - | - | - | -9.52 | - |
Investment in Securities | 2.7 | 17.17 | 6.84 | -0.18 | 80.66 |
Other Investing Activities | 0.56 | 2.82 | 0.83 | 0.02 | 0.12 |
Investing Cash Flow | 3.26 | 20 | 7.66 | -10.96 | 79.18 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | -0.93 | -11.25 | -1.16 | -2.51 | -2.42 |
Net Debt Issued (Repaid) | -0.93 | -11.25 | -1.16 | -2.51 | -2.42 |
Repurchase of Common Stock | - | - | - | - | -9.74 |
Common Dividends Paid | - | - | - | - | -36 |
Other Financing Activities | -0.68 | -4.3 | -0.03 | 22.56 | -3.38 |
Financing Cash Flow | -1.61 | -15.55 | -1.18 | 20.05 | -51.54 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.04 | 0.26 | 0.32 | 4.33 | -1.42 |
Net Cash Flow | -2.26 | -1.78 | -1.71 | -45.61 | -15.11 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.95 | -6.48 | -8.52 | -60.31 | -42.92 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | -8190.39% | -16300.00% | -19160.71% |
Free Cash Flow Per Share | -0.03 | -0.04 | -0.05 | -0.39 | -0.27 |
Levered Free Cash Flow | -2.12 | -5.94 | -5.44 | 6.26 | 23.33 |
Unlevered Free Cash Flow | -2.04 | -3.72 | -3.22 | 8.59 | 24.43 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.68 | 4.4 | 0.25 | 0.31 | 0.49 |
Cash Income Tax Paid | - | - | - | - | 0.09 |
Change in Working Capital | 0.55 | -0.1 | 2.41 | -20.32 | 2.16 |